Avectas
PrivateLast Round
Grant
Apr 22, 2021
Total Funding Raised
$31.28M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Avectas operates in Healthcare & Life Sciences and is based in Dublin. Its latest recorded funding round was a Grant round in April 2021.
Avectas is a biotechnology company that has developed a cell engineering platform intended to enable the ex vivo manufacture of gene-modified cell therapy products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avectas Comparables
Compare Avectas with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Indee Labs | 85% | |
| CellFE | 85% | |
| Kytopen | 84% |
For institutional investors. Book with your work email.
Avectas Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 22, 2021 | ||||
| Series C | Apr 16, 2020 | ||||
| VC Round | Apr 9, 2019 | ||||
| Grant | Mar 20, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Avectas Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| Disruptive Technologies Innovation Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors grew 66% MoM, from 637 to 1.1K.
- Jan 23, 2026
Monthly visitors increased 506% MoM.
For institutional investors. Book with your work email.
Avectas Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Avectas's valuation, stock price, and market status.
Is Avectas a public or private company?
Avectas is a private company.
What is the current stock price of Avectas?
Avectas is a private company, so its shares have no public market price. Caplight tracks Avectas's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Avectas worth (valuation)?
Valuation information for Avectas is not publicly available.
Can I buy Avectas stock?
Avectas shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Avectas's last funding round?
Avectas's most recent funding round was Grant on April 22, 2021.
Who are the main investors in Avectas?
Key investors in Avectas include European Union's Horizon Research and Innovation program, Disruptive Technologies Innovation Fund.
Will Avectas IPO soon?
No public IPO plans have been announced for Avectas.
How can I track Avectas secondary market activity?
Caplight tracks bids, offers, and trades in Avectas's shares on secondary markets.